# Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety

> **NCT06656806** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Trinity Hypertension & Metabolic Research Institute** · enrollment: 40 (estimated)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **DRUG:** Measure concentrations of CBD in spot urine collections from subjects treated with inhaled CBD
- **DRUG:** Determine the presence and concentration of CBD in subject's plasma with inhaled CBD

## Key facts

- **NCT ID:** NCT06656806
- **Lead sponsor:** Trinity Hypertension & Metabolic Research Institute
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-05-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-10-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06656806

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06656806, "Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06656806. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*